In metastatic PCa, the presence of combined alterations in TP53, PTEN, and RB1 has been linked to poorer OS, an increasing prevalence of ETS gene fusions, and gene expression patterns favoring aggressive disease and tumor progression [62]. The gene discussed is TP53; the disease is neoplasm.